Market Introduction
Infertility is defined as not being able to get pregnant or conceive. It can be primary infertility (refers to couples who cannot become pregnant after at least 1 year having sex without using birth control methods) and secondary infertility (refers to couples who cannot get pregnant more than once). There are many different infertility treatment devices and equipment options available for patients. Many factors are contributing to low fertility rate, thus in coming years, the number of patients seeking infertility treatment will raise. Many companies have developed novel device and procedures for simple, effective and cost effective fertility treatment.
Market Overview and Dynamics
The South & Central America infertility treatment devices and equipment market is expected to reach US$ 108.35 million in 2027 from US$ 62.69million in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as a high rise in the infertility rate and increased support by the government to promote fertility. However, lack of national regulatory bodies and stringent societal norms are likely to hamper the market growth.
Key Market Segments
Based on product, the infertility treatment devices and equipment market are segmented into ovum aspiration pumps, sperm separation devices, sperm analyzer systems, micromanipulator systems, incubators, and others. Based on procedure, the infertility treatment devices and equipment market is segmented into assisted reproductive technology, artificial insemination, and fertility surgery. The assisted reproductive technology is further subdivided into In Vitro Fertilization, intracytoplasmic sperm injection, and others. The artificial insemination is further subdivided into intrauterine insemination, intratubal insemination, and intracervical insemination. The fertility surgery is further subdivided into tubal ligation reversal, varicocelectomy, laparoscopy, and others. Based on end-user, the infertility treatment devices and equipment market, is segmented into fertility clinics, hospitals and other healthcare facilities, and clinical research institutes.
Major Sources and Companies Listed
Some of the major primary and secondary sources for infertility treatment devices and equipment market included in the report are Demographic and Health Survey, Latin American Network of Assisted Reproduction, Brazilian Federal Council of Medicine, and others.
Reasons to buy the report
- To understand the South & Central America infertility treatment devices and equipment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for infertility treatment devices and equipment market
- Efficiently plan M&A and partnership deals in South & Central America infertility treatment devices and equipment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Infertility treatment devices and equipment market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in South & Central America region
SOUTH & CENTRAL AMERICAINFERTILITY TREATMENT DEVICES AND EQUIPMENT MARKET SEGMENTATION
- Ovum Aspiration Pumps
- Sperm Separation Devices
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Others
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Others
- Artificial Insemination
- Intrauterine Insemination
- Intratubal Insemination
- Intracervical Insemination
- Fertility Surgery
- Tubal Ligation Reversal
- Varicocelectomy
- Laparoscopy
- Others
- Fertility Clinics
- Hospitals and Other Healthcare Facilities
- Clinical Research Institutes
By Country
- South & Central America
- Brazil
- Argentina
Company Profiles
- Cooper Surgical, Inc.
- Eppendorf AG
- Hamilton Thorne, Inc
- INVO Bioscience
- Vitrolife